In our study, serum ANGPTL6 was found for the first time to distinguish early primary HCC patients with normal serum AFP levels from the noncancer group, with a diagnostic accuracy of 71.7%. This evidence concerns the gene ANGPTL6 and hepatocellular carcinoma.